(Q79190111)

PubMed ID

17021642

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021642%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

The treatment of hormone-refractory prostate cancer: docetaxel and beyond (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1578715&resulttype=core&format=json

7 May 2020

1 reference

1 reference

Daniel P Petrylak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1578715&resulttype=core&format=json

7 May 2020

publication date

1 January 2006

1 reference

PubMed ID

17021642

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17021642%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1578715&resulttype=core&format=json

7 May 2020

volume

8 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1578715&resulttype=core&format=json

7 May 2020

page(s)

S48-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1578715&resulttype=core&format=json

Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer

7 May 2020

cites work

1 reference

12 December 2020

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.

1 reference

12 December 2020

Prognostic significance of plasma vascular endothelial growth factor levels in patients with hormone-refractory prostate cancer treated on Cancer and Leukemia Group B 9480.

1 reference

12 December 2020

Weekly high-dose calcitriol and docetaxel in advanced prostate cancer

1 reference

12 December 2020

Chemotherapy for androgen-independent prostate cancer.

1 reference

12 December 2020

The endothelin axis: emerging role in cancer

1 reference

12 December 2020

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system

1 reference

12 December 2020

Phase II randomized study of vaccine treatment of advanced prostate cancer (E7897): a trial of the Eastern Cooperative Oncology Group.

1 reference

12 December 2020

Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancer.

1 reference

12 December 2020

Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug

1 reference

12 December 2020

Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.

1 reference

12 December 2020

A phase I trial of pox PSA vaccines (PROSTVAC-VF) with B7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM) in patients with prostate cancer

1 reference

12 December 2020

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

12 December 2020

Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1578715&resulttype=core&format=json

7 May 2020

1 reference